Orchard Therapeutics PLC
Biotechnology
Healthcare
ORTX
18.93 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
16.41
52 week high
16.47
high
16.44
52 week low
1.32
low
16.41
growth
258.52 %
previous Close
16.45
P/E ratio
market cap
93.24 M
div yield
0
usd
Jun 2023
qoq
revenue
7.31 M
0.00 %
net incoming
-12.31 M
0.00 %
eps
0.00 %
0.00 %
eps surprise
94.96 %
net profit margin
-168.27 %
-168.00 %
operating incoming
-22.56 M
0.00 %
net change in cash
0.00 %
cash on hand
38.27 M
0.00 %
cost of revenue
2.19 M
0.00 %
top top